{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:44:02Z","timestamp":1769049842875,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Pacing and Electrophysiology Journal"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ipej.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T15:58:49Z","timestamp":1686239929000},"page":"158-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel mutation in N-terminal fragment of ryanodine receptor 2 causing catecholaminergic polymorphic ventricular tachycardia"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7920-2577","authenticated-orcid":false,"given":"Sania","family":"Jiwani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-3849","authenticated-orcid":false,"given":"Amit","family":"Noheria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ipej.2023.06.001_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002510","article-title":"Assessment and validation of a phenotype-enhanced variant classification framework to promote or demote RYR2 missense variants of uncertain significance","volume":"12","author":"Giudicessi","year":"2019","journal-title":"Circ Genom Precis Med"},{"issue":"9","key":"10.1016\/j.ipej.2023.06.001_bib2","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1253\/circj.CJ-17-1032","article-title":"Differential diagnosis between catecholaminergic polymorphic ventricular tachycardia and long QT syndrome type 1 - modified schwartz score","volume":"82","author":"Ozawa","year":"2018","journal-title":"Circ J"},{"issue":"11","key":"10.1016\/j.ipej.2023.06.001_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2004.028993","article-title":"Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients","volume":"42","author":"Postma","year":"2005","journal-title":"J\u00a0Med Genet"},{"issue":"2","key":"10.1016\/j.ipej.2023.06.001_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0735-1097(02)01946-0","article-title":"Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death","volume":"40","author":"Bauce","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ipej.2023.06.001_bib5","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1074\/jbc.M412954200","article-title":"Interaction of FKBP12.6 with the cardiac ryanodine receptor C-terminal domain","volume":"280","author":"Zissimopoulos","year":"2005","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.ipej.2023.06.001_bib6","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1074\/jbc.M210962200","article-title":"Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor)","volume":"278","author":"Masumiya","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.ipej.2023.06.001_bib7","first-page":"344","article-title":"Current topics in catecholaminergic polymorphic ventricular tachycardia","volume":"32","author":"Sumitomo","year":"2016","journal-title":"J\u00a0Arrhythm"},{"issue":"8","key":"10.1016\/j.ipej.2023.06.001_bib8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/europace\/euac030","article-title":"European heart rhythm association (EHRA)\/Heart rhythm society (HRS)\/Asia pacific heart rhythm society (APHRS)\/Latin American heart rhythm society (LAHRS) Expert Consensus statement on the state of genetic testing for cardiac diseases","volume":"24","author":"Wilde","year":"2022","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ipej.2023.06.001_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCRESAHA.120.316819","article-title":"RYR2 channel inhibition is the principal mechanism of flecainide action in CPVT","volume":"128","author":"Kryshtal","year":"2021","journal-title":"Circ Res"},{"issue":"14","key":"10.1016\/j.ipej.2023.06.001_bib10","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ipej.2023.06.001_bib11","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.hrthm.2018.06.046","article-title":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: a systematic review","volume":"15","author":"Roston","year":"2018","journal-title":"Heart Rhythm"},{"issue":"11","key":"10.1016\/j.ipej.2023.06.001_bib12","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1038\/npp.2012.107","article-title":"Effects of antidepressants, but not psychopathology, on cardiac sympathetic control: a longitudinal study","volume":"37","author":"Licht","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.ipej.2023.06.001_bib13","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/HJH.0b013e32829baae7","article-title":"Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?","volume":"25","author":"Barton","year":"2007","journal-title":"J\u00a0Hypertens"},{"issue":"4","key":"10.1016\/j.ipej.2023.06.001_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0306-4530(01)00002-6","article-title":"Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects","volume":"26","author":"Shores","year":"2001","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.ipej.2023.06.001_bib15","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/1060028013501994","article-title":"A\u00a0comparison of the risk of QT prolongation among SSRIs","volume":"47","author":"Funk","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.ipej.2023.06.001_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5830\/CVJA-2010-023","article-title":"Serotonin and catecholaminergic polymorphic ventricular tachycardia: a possible therapeutic role for SSRIs?","volume":"21","author":"Chen","year":"2010","journal-title":"Cardiovasc J Afr"}],"updated-by":[{"DOI":"10.1016\/j.ipej.2024.04.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000}}],"container-title":["Indian Pacing and Electrophysiology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629223000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629223000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T10:14:27Z","timestamp":1693304067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0972629223000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0972629223000645"],"URL":"https:\/\/doi.org\/10.1016\/j.ipej.2023.06.001","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ipej.2024.04.002","asserted-by":"object"}]},"ISSN":["0972-6292"],"issn-type":[{"value":"0972-6292","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel mutation in N-terminal fragment of ryanodine receptor 2 causing catecholaminergic polymorphic ventricular tachycardia","name":"articletitle","label":"Article Title"},{"value":"Indian Pacing and Electrophysiology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ipej.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Indian Heart Rhythm Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}